Researcher Database

Okuyama Hiromi

FacultyAdvanced Cancer Translational Research Institute
Position
Last Updated :2022/12/23

Researcher

基本情報

Profile and Settings

  • 氏名

    Okuyama Hiromi

Affiliation

  • Advanced Cancer Translational Research Institute

Location

  • Hatanodai Campus

Degree

  • Doctor of Pharmaceutical Science, Showa University, Nov. 2018

Achievements

Published Papers

  • Application of personal health record in enhancing the quality of life in patients with breast cancer who received adjuvant hormonal therapy., TAKADA Fuka;OKUYAMA Hiromi;中村 清吾;FUJITA Ken-ichi, Eur J Breast Health, :e, Feb. 2022, Peer-reviewed
  • BRCAness as a prognostic indicator in patients with early breast cancer., LIU Lei;MATSUNAGA Yuki;TSURUTANI Junji;AKASHI-TANAKA Sadako;MASUDA Hiroko;IDE Yoshimi;HASHIMOTO Rikako;INUZUKA Mayuko;WATANABE Chie;TARUNO Kanae;SAWADA Terumasa;OKUYAMA Hiromi;ATA Arisa;KUWAYAMA Takashi;NAKAYAMA Sayuka;TONOUCHI Yumi;NAKAMURA Seigo, Sci Rep, 10(1):21173, Dec. 2020, Peer-reviewed
  • Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial, HANDA Satoko;OKUYAMA Hiromi;YAMAMOTO Hitomi;NAKAMURA Seigo;KATO Yasuhisa, Clin Breast Cancer, 20(3):201 - 208, Jun. 2020, Peer-reviewed
  • Differences in perception of breast cancer treatment between patients, physicians, and nurses and unmet information needs in Japan, SAKAI Haruna;UMEDA Megumi;OKUYAMA Hiromi;NAKAMURA Seigo, Support Care Cancer, :e, Sep. 2019, Peer-reviewed
  • QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer., OKUYAMA Hiromi;NAKAMURA Seigo;AKASHI-TANAKA Sadako;SAWADA Terumasa;KUWAYAMA Takashi;HANDA Satoko;KATO Yasuhisa, Eur J Breast Health, 14(4):194 - 198, Oct. 2018, Peer-reviewed
  • Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer., TAGAWA Nao;SUGIYAMA Erika;TAJIMA Masataka;SASAKI Yasutsuna;NAKAMURA Seigo;OKUYAMA Hiromi;SHIMIZU Hisanori;SATO Vilasinee Hirunpanich;SASAKI Tadanori;SATO Hitoshi, Cancer Chemother Pharmacol, 80(4):841 - 849, Oct. 2017, Peer-reviewed
  • Development of Support System for Breast Cancer Patients: Managing Side Effects through an Internet-Based System, OKUYAMA Hiromi;加藤 裕久;HANDA Satoko;NARA Tamaki;SONODA Masayuki;BABA Mai;AKAHORI Hiromi;KURODA Eiji;NAKAMURA Seigo, 癌と化学療法, 43(1):85 - 90, Jan. 2016, Peer-reviewed
  • BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapy., AKASHI-TANAKA Sadako;WATANABE Chie;TAKAMARU Tomoko;KUWAYAMA Takashi;IKEDA Murasaki;OHYAMA Hiroto;MORI Miki;YOSHIDA Reiko;HASHIMOTO Rikako;SAWADA Terumasa;ENOKIDO Katsutoshi;HIROTA Yuko;OKUYAMA Hiromi;NAKAMURA Seigo, Clin Breast Cancer, 15(1):80 - 85, Feb. 2015, Peer-reviewed

Presentations

  • Developing a mobile application to support self-management for adverse drug reactions in patients with breast cancer., 半田 智子;奥山 裕美;山本 仁美;中村 清吾;加藤 裕久, 日本薬学会第138年会, 28 Mar. 2018, 金沢
  • ドセタキセル点滴静注の後発医薬品における安全性評価 製剤の違いによる有害事象発現への影響, 田川 菜緒;田島 正教;杉山 恵理花;奥山 裕美;中村 清吾;佐々木 康綱;佐々木 忠徳;佐藤 均, 日本薬学会第137年会, 25 Mar. 2017, 仙台
  • BRCA1/2変異陽性患者に発症したluminal乳癌の多遺伝子解析による悪性度診断, 井手 佳美;犬塚 真由子;吉田 玲子;阿多 亜里沙;中山 紗由香;殿内 祐美;小杉 奈津子;池田 紫;渡辺 智子;佐藤 大樹;垂野 香苗;橋本 梨佳子;増田 紘子;高丸 智子;森 美樹;桑山 隆志;明石 定子;澤田 晃暢;奥山 裕美;中村 清吾, 第24回日本乳癌学会学術総会, 16 Jun. 2016, 東京
  • ロゼックスゲルの使用経験, 澤田 晃暢;奥山 裕美;中村 清吾, 第115回日本皮膚科学会総会イブニングセミナー, 03 Jun. 2016
  • 乳癌薬物療法に伴う副作用マネジメントとQOLに関する研究, 奥山 裕美;中村 清吾;明石 定子;澤田 晃暢;桑山 隆志;加藤 裕久, 第53回日本癌治療学会学術集会, 29 Oct. 2015, 京都


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.